These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28625466)

  • 1. First Pediatric Patient With Neuromyelitis Optica and Sjögren Syndrome Successfully Treated With Tocilizumab.
    Marino A; Narula S; Lerman MA
    Pediatr Neurol; 2017 Aug; 73():e5-e6. PubMed ID: 28625466
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuromyelitis optica spectrum disorder complicated with Sjogren syndrome successfully treated with tocilizumab: A case report.
    Komai T; Shoda H; Yamaguchi K; Sakurai K; Shibuya M; Kubo K; Takahashi T; Fujio K; Yamamoto K
    Mod Rheumatol; 2016; 26(2):294-6. PubMed ID: 24313919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Sjögren Syndrome in a Child with a Neuromyelitis Optica Spectrum Disorder.
    Kornitzer JM; Kimura Y; Janow GL
    J Rheumatol; 2016 Jun; 43(6):1260-1. PubMed ID: 27252507
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuromyelitis optica spectrum disorder complicated with Sjögren's syndrome: first pediatric case responsive to mycophenolate mofetil treatment.
    Fang GL; Fang W; Zheng Y; Zhang YX
    Acta Neurol Belg; 2021 Aug; 121(4):1065-1067. PubMed ID: 33136271
    [No Abstract]   [Full Text] [Related]  

  • 5. Tocilizumab for refractory organising pneumonia associated with Sjögren's disease.
    Justet A; Ottaviani S; Dieudé P; Taillé C
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25976199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of rituximab in the therapy of neuromyelitis optica in a patient with Sjogren's syndrome: case-report and literature review.
    Torgashina AV; Vasilyev VI
    Ter Arkh; 2018 May; 90(5):76-80. PubMed ID: 30701893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible stenosis of large cerebral arteries in a patient with combined Sjögren's syndrome and neuromyelitis optica spectrum disorder.
    Ii Y; Shindo A; Sasaki R; Naito Y; Tanaka K; Kuzuhara S
    Rheumatol Int; 2008 Oct; 28(12):1277-80. PubMed ID: 18493764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of pathology-proven neuromyelitis optica spectrum disorder with Sjögren syndrome manifesting aphasia and apraxia due to a localized cerebral white matter lesion.
    Sawada J; Orimoto R; Misu T; Katayama T; Aizawa H; Asanome A; Takahashi K; Saito T; Anei R; Kamada K; Miyokawa N; Takahashi T; Fujihara K; Hasebe N
    Mult Scler; 2014 Sep; 20(10):1413-6. PubMed ID: 24986696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary Sjögren's syndrome and neuromyelitis optica].
    Chourkani N; El Moutawakil B; Sibai M; Bourezgui M; Rafai MA; Slassi I
    Rev Med Interne; 2010 Sep; 31(9):e13-5. PubMed ID: 20554086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid-responsive Devic's variant in Sjögren's syndrome.
    Mochizuki A; Hayashi A; Hisahara S; Shoji S
    Neurology; 2000 Mar; 54(6):1391-2. PubMed ID: 10746622
    [No Abstract]   [Full Text] [Related]  

  • 11. Sjögren's syndrome associated with Crohn's disease successfully treated with adalimumab.
    Tursi A
    J Crohns Colitis; 2012 Mar; 6(2):263. PubMed ID: 22325185
    [No Abstract]   [Full Text] [Related]  

  • 12. First report of improvement of coeliac disease in a patient with Sjögren's syndrome treated with rituximab.
    Nikiphorou E; Hall FC
    Rheumatology (Oxford); 2014 Oct; 53(10):1906-7. PubMed ID: 24729401
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient with neuromyelitis optica spectrum disorder combined with Sjögren's syndrome relapse free following tacrolimus treatment.
    Zheng X; Zhang X; Liu X; Mu W; Yang W; Liu Y; Ge P; Li H
    Intern Med; 2014; 53(20):2377-80. PubMed ID: 25318807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syringomyelia-like syndrome in neuromyelitis optica spectrum disorder complicated with Sjogren's syndrome: a case report.
    Li X; Lu Z; Wang Y
    BMC Neurol; 2018 Oct; 18(1):168. PubMed ID: 30301458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete remission of protein-losing gastroenteropathy associated with Sjögren's syndrome by B cell-targeted therapy with rituximab.
    Uraoka Y; Tanigawa T; Watanabe K; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Watanabe T; Fujiwara Y; Arakawa T
    Am J Gastroenterol; 2012 Aug; 107(8):1266-8. PubMed ID: 22859008
    [No Abstract]   [Full Text] [Related]  

  • 16. Vasculitis in Sjögren's Syndrome.
    Scofield RH
    Curr Rheumatol Rep; 2011 Dec; 13(6):482-8. PubMed ID: 21870104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromyelitis optica spectrum disorder as an initial presentation of primary Sjögren's syndrome.
    Kahlenberg JM
    Semin Arthritis Rheum; 2011 Feb; 40(4):343-8. PubMed ID: 20655576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinally extensive transverse myelitis.
    Tobin WO; Weinshenker BG; Lucchinetti CF
    Curr Opin Neurol; 2014 Jun; 27(3):279-89. PubMed ID: 24792338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical characteristics of primary Sjögren syndrome with neuromyelitis optica].
    Qiao L; Luo Y; Zhang LL; Zhao LD; Wang Q; Xu Y; Zhao Y
    Zhonghua Nei Ke Za Zhi; 2013 Sep; 52(9):745-8. PubMed ID: 24314164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired factor VIII inhibitor in Sjögren's syndrome.
    Vintimilla M; Joseph A; Ranganathan P
    Arthritis Care Res (Hoboken); 2010 Jul; 62(7):1047-50. PubMed ID: 20589701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.